Message from CEO | About Us

We propose a compact and streamlined development plan which targets especially oncology and refractory disease whose needs are high among patients
We promote pharmaceutical-related companies to diversified service to contribute to reduce the drug-lag
We have established a position as a company who contributes to open-innovation in drug development, which differentiate us from other companies clearly by undertaking clinical development of drugs comprehensively

To promote the business surely with high-quality and high-speed, we have experts in development, Regulatory Affairs, CMC, Licensing etc., who have had a lot of experiences and accomplished tasks successfully, and then we comprise the organizations which are feasible to propose clients strategically.